International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-3 doi: 10.5281/zenodo.15708687
Original Research Article
Association Between Serum Calcium Levels and Blood Pressure with Infarct Volume in Acute Ischemic Stroke: A Cross-Sectional Study
Published
June 11, 2025
Abstract

Background and Objectives: Calcium homeostasis and blood pressure regulation play crucial roles in stroke pathophysiology. This study investigated associations between serum calcium levels, blood pressure parameters, and infarct volume in acute ischemic stroke.

Methods: We conducted a cross-sectional study of 100 consecutive patients with acute ischemic stroke presenting within 24 hours of symptom onset. Serum calcium levels were measured within 6 hours of admission. Infarct volume was calculated using semi-automated volumetric analysis of neuroimaging. Multiple linear regression analyzed independent predictors of infarct volume.

Results: Mean age was 64.5±12.3 years with 58% males. Median infarct volume was 28.5 mL (IQR: 12.3-68.4). Corrected calcium showed significant correlation with infarct volume (r=0.45, p<0.001), as did systolic blood pressure (r=0.38, p<0.001). In multivariable analysis, each 0.1 mmol/L increase in corrected calcium was associated with 8.24 mL larger infarct volume (95% CI: 3.98-12.50, p<0.001). Patients in the highest calcium tertile (>2.46 mmol/L) had median infarct volumes of 48.6 mL compared to 16.8 mL in the lowest tertile (p<0.001). Thirty-day mortality was 24.2% in the highest versus 6.1% in the lowest calcium tertile (p=0.044).

Conclusion: Elevated serum calcium levels are independently associated with larger infarct volumes in acute ischemic stroke. These findings suggest calcium measurement may provide prognostic information and identify high-risk patients requiring aggressive management.

Recommended Articles
Loading Image...
Volume-6, Issue-3
Citations
1595 Views
229 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved